1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 41 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2002Guidelines for the treatment of postmenopausal osteoporosis for general practitionersO'Neill, S.; Sambrook, P.; Diamond, T.; Ebeling, P.; Ferris, L.; Flicker, L.; Findlay, D.; Fiatarone-Singh, M.; Lord, S.; MacLennan, A.; Markwell, A.; Nowson, C.; Pocock, N.; Williamson, M.
2004Guidelines for the management of postmenopausal osteoporosis for GPsO'Neill, S.; MacLennan, A.; Diamond, T.; Ebeling, P.; Findlay, D.; Flicker, L.; Markwell, A.; Nowson, C.; Pocock, N.; Sambrook, P.; Fiatarone-Singh, M.
2007Microarray gene expression profiling of osteoarthritic bone suggests altered bone remodelling, WNT and transforming growth factor-β/bone morphogenic protein signallingHopwood, B.; Tsykin, A.; Findlay, D.; Fazzalari, N.
2001Regulation of calcitonin receptor by glucocorticoid in human osteoclast-like cells prepared in vitro using receptor activator of nuclear factor-kB ligand and macrophage colony-stimulating factorWada, S.; Yasuda, S.; Nagai, T.; Maeda, T.; Kitahama, S.; Suda, S.; Findlay, D.; Iitaka, M.; Katayama, S.
1997Regulation by calcitonin and glucocorticoids of calcitonin receptor gene expression in mouse osteoclastsWada, S.; Udagawa, N.; Akatsu, T.; Nagata, N.; Martin, T.; Findlay, D.
2005Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free mediumAtkins, G.; Kostakis, P.; Welldon, K.; Vincent, C.; Findlay, D.; Zannettino, A.
2006TWEAK is a novel arthritogenic mediatorPerper, S.; Browning, B.; Burkly, L.; Weng, S.; Gao, C.; Giza, K.; Su, L.; Tarilonte, L.; Crowell, T.; Rajman, L.; Runkel, L.; Scott, M.; Atkins, G.; Findlay, D.; Zheng, T.; Hess, H.
2012Progression of periacetabular osteolytic lesionsHowie, D.; Neale, S.; Martin, W.; Costi, K.; Kane, T.; Stamenkov, R.; Findlay, D.
2004Sensitivity of fresh isolates of soft tissue sarcoma, osteosarcoma and giant cell tumour cells to Apo2L/TRAIL and doxorubicinBouralexis, S.; Clayer, M.; Atkins, G.; Labrinidis, A.; Hay, S.; Graves, S.; Findlay, D.; Evdokiou, A.
2002Calcitonin decreases the adherence and survival of HEK-293 cells by a caspase-independent mechanismFindlay, D.; Raggatt, L.; Bouralexis, S.; Hay, S.; Atkins, G.; Evdokiou, A.

Discover